PBRM1 and nonpapillary renal cell carcinoma: These findings suggested that GATM protein levels are associated with PBRM1 mutation status and less aggressive phenotypes and exhibit potential clinical utility as a prognostic marker for metastatic ccRCC with ICIs treatment.